← Leaderboards
Issa J. Dahabreh
Harvard University D/B/A Harvard School Of Public Health
$2,515,094
Attributed
$3,640,037
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,640,037 · 2
By mechanism
R01$3,640,037 · 2
Top collaborators
- Robert Yeh3 shared
Others in their field
Other Rising Stars on “Follow-Up”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Carolina Porras · Fundacion Inciensa$10,814,023
- James Cappo · National Jewish Health$9,298,220
- Christine W Hockett · Avera Mckennan$8,908,366
- Donald Lloyd-Jones · Boston University (Charles River Campus)$8,894,939
- Michael E. Roth · Public Health Institute$8,201,777
Research focus
Follow-UpRandomized TrialResponseDesignResearch DesignMethodologyTarget PopulationsSample SizeTreatment EffectEligibility DeterminationHealthcare SystemsMachine LearningInfluenza Virus VaccineMachine Learning MethodInfluenza VaccinationInterestModernizationFlexibilityAccountingEnrollmentFundingData CollectionAdjuvantDependence
Grant awards (7)
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$737,416
R01 · FY2025 · HL
Methods for generalizing inferences from cluster randomized controlled trials to target populations$340,176
R01 · FY2025 · LM · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$735,551
R01 · FY2024 · HL
Methods for generalizing inferences from cluster randomized controlled trials to target populations$340,155
R01 · FY2024 · LM · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$776,920
R01 · FY2023 · HL
Methods for generalizing inferences from cluster randomized controlled trials to target populations$340,138
R01 · FY2023 · LM · contact PI
Methods for generalizing inferences from cluster randomized controlled trials to target populations$369,681
R01 · FY2022 · LM · contact PI